000162041 001__ 162041 000162041 005__ 20251017144639.0 000162041 0247_ $$2doi$$a10.1155/ane/5587883 000162041 0248_ $$2sideral$$a144633 000162041 037__ $$aART-2025-144633 000162041 041__ $$aeng 000162041 100__ $$aRodríguez-Montolío, Joana 000162041 245__ $$aImpulsivity in Male Episodic Cluster Headache 000162041 260__ $$c2025 000162041 5060_ $$aAccess copy available to the general public$$fUnrestricted 000162041 5203_ $$aBackground: Cluster headache (CH) is the most prevalent trigeminal‐autonomic cephalalgia. Research evidence supports the hypothesized involvement of the posterior hypothalamus, the trigeminal‐vascular system, and other central pain‐processing regions in the pathogenesis of pain. Because of the role of the hypothalamus, CH patients should be at greater risk of developing an altered emotional response. Impulsivity is associated with depression, bipolar disorders, suicide attempts, and addictive disorders, which can be frequent in CH.Objective: Our objective is to evaluate the prevalence of impulsivity in CH patients.Methods: This is a cross‐sectional observational study. Barratt Impulsiveness Scale (BIS‐11) was administered to evaluate impulsivity.Results: Fifty CH patients outside the bout and 60 matched controls were included. Patients were recruited from an outpatient headache unit. The percentage of episodic CH patients with a diagnosis of impulsivity (BIS‐11 ≥ 73) was 14.2% compared to 1.6% in the control group (p = 0.02). The mean score on the BIS‐11 was 58.5 (SD: 14.3) in the case group and 57.1 (SD: 9.2) in the control group. Although the global score on the scale did not differ between both groups, there were differences in cognitive (16.2 [SD: 4.4] vs. 14.5 [SD: 3.5]; p = 0.01) but not in motor and nonplanning impulsivity.Conclusion: Our findings suggest that CH patients have greater cognitive impulsivity. If impulsivity plays an important role in the risk of suicide and substance use disorders, early detection and an effective multidisciplinary management could reduce CH‐related burden and impact. 000162041 540__ $$9info:eu-repo/semantics/openAccess$$aby$$uhttps://creativecommons.org/licenses/by/4.0/deed.es 000162041 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion 000162041 700__ $$aCajape-Mosquera, Javier$$uUniversidad de Zaragoza 000162041 700__ $$adel Moral-Sahuquillo, Belén 000162041 700__ $$aLasry-Mizzi, Miriam 000162041 700__ $$0(orcid)0000-0002-0002-8041$$aBellosta-Diago, Elena 000162041 700__ $$0(orcid)0000-0001-5139-6031$$aSantos-Lasaosa, Sonia$$uUniversidad de Zaragoza 000162041 7102_ $$11007$$2610$$aUniversidad de Zaragoza$$bDpto. Medicina, Psiqu. y Derm.$$cArea Medicina 000162041 773__ $$g2025, 1 (2025), 7 pp.$$pActa neurol. Scand.$$tACTA NEUROLOGICA SCANDINAVICA$$x0001-6314 000162041 8564_ $$s766427$$uhttps://zaguan.unizar.es/record/162041/files/texto_completo.pdf$$yVersión publicada 000162041 8564_ $$s2030673$$uhttps://zaguan.unizar.es/record/162041/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada 000162041 909CO $$ooai:zaguan.unizar.es:162041$$particulos$$pdriver 000162041 951__ $$a2025-10-17-14:31:13 000162041 980__ $$aARTICLE